Microneedling with topical autologous Platelet rich plasma versus intralesional Triamcinolone acetonide in Alopecia Areata

Phase 4

• Conditions: Health Condition 1: L638- Other alopecia areata

• Registration Number: CTRI/2021/03/031963
• Lead Sponsor: Dr Surabhi Dayal

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

Clinically diagnosed as Alopecia Areata of the scalp less than or equal to 5 patches and less than or equal to 25 % scalp involvement and who have not taken any treatment for hair loss in the past 3 months and are willing to consent for enrollment in the study

Exclusion Criteria

Patients with history of bleeding disorders,on anticoagulant medications,with an active infection at local site,having keloidal tendency, having psoriasis or lichen planus because of risk of Koebner phenomenon or any other dermatological disease,having alopecia totalis or alopecia universalis,who had taken any treatment for hair-loss in the past 3 months,with history of hypersensitivity to formulation used in the study,Severe systemic illness or malignancy,Pregnant and lactating mothers.

Study & Design

• Study Type: Interventional
• Study Design: Not specified